Home » GLP-1 Guide » Ozempic and Heart Health South Africa

Ozempic and Heart Health in South Africa: Can Semaglutide Protect Your Heart?

Updated May 2026 • Medically reviewed content • 12 min read

South Africa has one of the highest rates of cardiovascular disease in Africa. Heart disease is our number one killer, responsible for roughly 1 in 6 deaths. At the same time, obesity rates are climbing fast — over 30% of South African adults are now classified as obese, a major driver of heart attacks and strokes.

Then came the SELECT trial — a landmark study that changed everything we know about Ozempic (semaglutide). It proved that this GLP-1 medication does more than help you lose weight. It can actively reduce your risk of heart attack, stroke, and cardiovascular death by 20%.

For South Africans already struggling with the twin burdens of obesity and heart disease, this is enormous news. Here is what you need to know.

Medical disclaimer: This article is for informational purposes only. Ozempic is a prescription medication. Always consult your doctor or cardiologist before starting any new treatment. Never self-medicate with semaglutide for heart protection.

The SELECT Trial: What South Africans Need to Know

The Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial was published in the New England Journal of Medicine in November 2023. It was the largest cardiovascular outcomes trial ever conducted for an anti-obesity medication.

17,604
Participants enrolled
20%
Reduction in MACE events
39.8
Months mean follow-up
41
Countries participated

Key SELECT Trial Findings

Outcome Semaglutide Group Placebo Group Risk Reduction
MACE (primary endpoint) 6.5% 8.0% 20% lower
Heart attack (non-fatal MI) 2.6% 3.3% 28% lower
Stroke (non-fatal) 1.5% 1.8% 7% lower
Cardiovascular death 2.5% 3.0% 15% lower
Heart failure events 1.4% 2.0% 18% lower
All-cause mortality 4.3% 4.6% Trend toward lower
The game-changer: SELECT participants did not have diabetes. They had obesity/overweight plus established cardiovascular disease. This proved that semaglutide protects the heart independently of blood sugar control — a finding that fundamentally changed how doctors view this medication.

How Does Semaglutide Protect the Heart?

Semaglutide does not just help you shed kilograms. Research suggests it works through multiple cardiovascular pathways:

1. Reduces Inflammation

Chronic inflammation is a key driver of atherosclerosis (plaque build-up in arteries). Semaglutide has been shown to reduce C-reactive protein (CRP) — a marker of systemic inflammation — by up to 40%. In the SELECT trial, CRP levels dropped significantly in the semaglutide group, and researchers believe this anti-inflammatory effect is a major reason for the cardiovascular benefit.

2. Improves Blood Pressure

High blood pressure is the leading modifiable risk factor for heart disease in South Africa. Semaglutide typically reduces systolic blood pressure by 3-5 mmHg — a clinically meaningful drop that compounds over time. For context, a 5 mmHg reduction in systolic BP is associated with roughly a 10% reduction in major cardiovascular events.

3. Fixes Cholesterol and Lipids

Semaglutide improves your lipid profile across the board:

4. Reduces Visceral Fat

Not all fat is equal. Visceral fat — the deep belly fat surrounding your organs — is the most dangerous type for heart health. Semaglutide preferentially reduces visceral fat, with imaging studies showing up to 30% reduction in visceral adipose tissue. This is far more cardiovascular benefit than losing the same number of kilograms from subcutaneous fat.

5. Direct Vascular Effects

GLP-1 receptors exist on blood vessel walls and in the heart itself. Emerging research suggests semaglutide may:

South Africa's Cardiovascular Crisis: Why This Matters Here

South Africa faces a unique "collision" of risk factors that makes the SELECT trial findings especially relevant:

Risk Factor SA Prevalence Semaglutide Impact
Obesity (BMI ≥30) ~31% of adults 15-17% body weight loss
Hypertension ~35% of adults 3-5 mmHg BP reduction
Type 2 diabetes ~12.7% (4.6 million) HbA1c reduction of 1.0-1.8%
High cholesterol Undertreated nationally Triglycerides down 15-25%
Physical inactivity ~50% of women, ~30% of men Weight loss enables more activity

The combination of obesity, hypertension, and diabetes — sometimes called "metabolic syndrome" — is rampant in South Africa. And semaglutide addresses all three simultaneously.

SA stat: The Heart and Stroke Foundation South Africa estimates that cardiovascular diseases account for almost 1 in 6 deaths nationally. In urban areas, the rate is even higher due to processed food diets high in salt and fat.

Who Should Consider Ozempic for Heart Protection?

Based on the SELECT trial criteria and current SA prescribing guidelines, you may be a candidate if you have:

Even if you do not have established heart disease, your doctor may consider semaglutide if you have a high Framingham Risk Score or multiple metabolic risk factors. SA cardiologists are increasingly using semaglutide as part of a comprehensive chronic disease management approach.

Who Should NOT Use Ozempic for Heart Health

Contraindications include:
  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • History of pancreatitis (use with extreme caution)
  • Severe gastrointestinal disease (gastroparesis)
  • Pregnancy or planning to conceive within 2 months
  • BMI below 27 without diabetes (lean individuals with heart disease need different strategies)

Ozempic vs Other Heart Medications: Where Does It Fit?

Semaglutide does not replace your existing heart medications. It adds another layer of protection. Here is how it compares:

Medication CV Risk Reduction Weight Effect Monthly Cost (ZAR)
Semaglutide (Ozempic/Wegovy) 20% MACE reduction -15 to -17% body weight R3,200 - R5,200
Statins (e.g., atorvastatin) 25-35% MACE reduction Neutral R80 - R350
ACE inhibitors (e.g., enalapril) 20-25% (in high-risk) Neutral R50 - R200
Aspirin (secondary prevention) 15-20% vascular events Neutral R30 - R60
SGLT2 inhibitors (e.g., empagliflozin) 14% MACE reduction -2 to -3 kg R700 - R1,200
Tirzepatide (Mounjaro) CV trial ongoing (SURPASS-CVOT) -20 to -25% body weight R4,000 - R6,500
Important: If you are already on statins, blood pressure medication, or aspirin, do NOT stop them to start Ozempic. Semaglutide works best alongside standard cardiac medications, not as a replacement. The SELECT trial participants were on optimal background therapy including statins (90%) and anti-hypertensives (88%).

Cost of Ozempic for Heart Health in South Africa

The biggest barrier for most South Africans is cost. Here is the current pricing landscape:

Private Sector Pricing (2026)

Product Dose Monthly Cost Annual Cost
Ozempic 0.5mg pen 0.5mg/week ~R3,200 ~R38,400
Ozempic 1mg pen 1mg/week ~R4,200 ~R50,400
Wegovy 2.4mg pen 2.4mg/week (SELECT dose) ~R5,200 ~R62,400
Generic semaglutide Varies ~R1,800 - R2,500 ~R21,600 - R30,000

You can find Ozempic at Dis-Chem, Clicks, and independent pharmacies across Gauteng, Western Cape, and KZN. Prices vary — shop around and ask about loyalty programme discounts.

Medical Aid Coverage Strategies

Getting your medical aid to pay for semaglutide requires strategic coding and motivation:

Pro tip: Ask your doctor to include both your cardiovascular diagnosis and metabolic syndrome coding in the motivation letter. This strengthens your case significantly. The combination of ICD-10 codes for obesity (E66), diabetes (E11), and ischaemic heart disease (I25) makes denials harder to sustain.

Heart-Healthy Eating While on Ozempic: SA Meal Guide

Semaglutide works best when combined with a heart-healthy diet. Here is a practical day of eating that is budget-friendly, heart-protective, and works with Ozempic's appetite-suppressing effects:

Sample Heart-Healthy Ozempic Day (under R80)

Meal What to Eat Estimated Cost
Breakfast Oats with cinnamon, walnuts (2 tbsp), and half a banana. Rooibos tea (naturally caffeine-free, rich in antioxidants) ~R15
Lunch Tinned pilchards (Lucky Star) on brown bread with sliced tomato and avocado. Side salad with lemon dressing ~R25
Snack Small handful of biltong (30g) and an apple ~R15
Dinner Grilled chicken thigh (skin removed) with roasted butternut, steamed green beans, and brown rice (small portion). Season with garlic, turmeric, and black pepper ~R25

Heart-Healthy Foods Available at Shoprite, Checkers, and Pick n Pay

Ozempic tip: Because semaglutide reduces appetite, you may eat smaller portions. Make every bite count for heart health — prioritise omega-3 fats (pilchards, walnuts), fibre (oats, lentils), and potassium-rich foods (banana, butternut, avocado) that support cardiovascular function. Avoid processed meats like polony and russians — their high sodium and preservative content counteracts Ozempic's heart benefits.

Side Effects to Watch: Heart-Specific Concerns

While semaglutide is generally well-tolerated, there are side effects that matter specifically for cardiac patients:

Common Side Effects (usually temporary)

Serious Concerns (rare but important)

If you have heart failure: The SELECT trial showed semaglutide reduced heart failure events by 18%. However, if you have severe heart failure (NYHA Class III-IV), discuss with your cardiologist whether the GI side effects (nausea, vomiting, reduced intake) could compromise your nutritional status. Cardiac cachexia and unintended weight loss in advanced heart failure are different from therapeutic weight loss.

What SA Doctors Are Saying

South African cardiologists and endocrinologists are increasingly incorporating semaglutide into cardiovascular risk management. Here is the current landscape:

Starting Ozempic for Heart Health: Practical Steps

  1. See your GP or cardiologist. Discuss the SELECT trial findings and whether you are a candidate. Bring your recent blood results (lipids, HbA1c, kidney function, CRP)
  2. Get baseline tests. Before starting, your doctor should check: fasting lipid panel, HbA1c, renal function (eGFR), thyroid function, and resting ECG
  3. Start low, go slow. Ozempic is titrated: 0.25mg/week for 4 weeks, then 0.5mg, then 1mg. This minimises GI side effects. The SELECT dose (2.4mg) requires Wegovy pens
  4. Coordinate medications. Your doctor may need to adjust blood pressure medications (risk of hypotension) and diabetes medications (risk of hypoglycaemia) as you lose weight
  5. Monitor regularly. Follow-up at 4 weeks, 12 weeks, then quarterly. Track weight, blood pressure, lipids, and HbA1c
  6. Combine with lifestyle. Semaglutide is not a replacement for exercise, healthy eating, and adequate sleep. The SELECT trial participants were encouraged to maintain 150 minutes of moderate activity per week

Beyond Ozempic: Other GLP-1 Options for Heart Health

Semaglutide is not the only GLP-1 medication with cardiovascular data:

Medication CV Outcome Trial MACE Result Available in SA?
Semaglutide (Ozempic/Wegovy) SELECT, SUSTAIN-6 20% reduction (SELECT) Yes
Liraglutide (Saxenda/Victoza) LEADER 13% reduction Yes
Dulaglutide (Trulicity) REWIND 12% reduction Yes
Tirzepatide (Mounjaro) SURPASS-CVOT (ongoing) Results expected 2026-2027 Limited
Oral semaglutide (Rybelsus) PIONEER-6, SOUL SOUL: 14% reduction Yes
Oral option: If you cannot tolerate injections, Rybelsus (oral semaglutide) is available in SA. The SOUL trial (2024) showed a 14% MACE reduction in type 2 diabetes patients. It costs approximately R2,500-R3,500/month at Dis-Chem.

The Bottom Line: Is Ozempic Worth It for Your Heart?

The evidence is clear: semaglutide offers real, measurable cardiovascular protection for people with obesity and heart disease. The 20% reduction in MACE events from SELECT is comparable to the benefit of adding a statin — and it comes with significant weight loss as a bonus.

For South Africans facing both an obesity epidemic and a cardiovascular crisis, this represents a genuine therapeutic advance. The main barriers remain cost and access.

Summary:
  • SELECT trial proved 20% reduction in heart attacks, strokes, and cardiovascular death
  • Benefits occur even without diabetes — obesity + heart disease is enough
  • Works through multiple pathways: anti-inflammatory, BP reduction, lipid improvement, visceral fat loss
  • Does NOT replace statins, BP meds, or aspirin — it adds to them
  • Monthly cost: R3,200-R5,200 depending on dose
  • Medical aid coverage possible with proper motivation and coding
  • Always start under cardiologist or endocrinologist supervision

Learn More About GLP-1 Medications

Explore our comprehensive guides to Ozempic, semaglutide alternatives, and weight loss strategies for South Africans.

Read the GLP-1 Guide

Related Reading

Last updated: May 2026. This article is reviewed quarterly to reflect the latest cardiovascular research and South African pricing. Sources include the SELECT trial (NEJM 2023), SUSTAIN-6 trial, SA Heart Association guidelines, and SAHPRA registration data.